Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2025-12-25 @ 8:21 PM
Study NCT ID:
NCT07072169
Status:
RECRUITING
Last Update Posted:
2025-07-18
First Post:
2025-05-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL)
Sponsor:
Ruijin Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ABO2203-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None